Implantica AG Stock

IMP A SDB

SE0014855029

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 12:00:00 2026-09-03 EDT			5-day change	1st Jan Change
59.40 ^SEK	+0.17%		-0.34%	+18.56%

08-25	Implantica to hold Capital Markets Day on September 9 on US launch	FW
08-24	Quadient appeals, Stellantis struggles

Last Transcript : Implantica AG

Implantica AG, Q2 2026 Earnings Call, Aug 21, 2026

08-21

More transcripts

Analysts' recommendations : Implantica AG

08-24	Pareto reiterates buy on Implantica, raises target price to 90 kronor	FW
08-24	Pareto Securities raises its target price for Implantica to 90 kronor (73), reiterates buy	FW
25-10-16	Pareto Raises Target Price for Implantica as FDA Approval Nears Turning Point	FW
25-10-16	Pareto Securities Raises Target Price for Implantica to 73 Kronor (54), Reiterates Buy	FW
25-10-13	Implantica Completes Key Milestone in US FDA Review for Acid Reflux Device	MT

More recommendations

Press Releases : Implantica AG

08-25	Implantica to host Capital Markets Day in Stockholm on September 9	AQ
08-21	Implantica publishes Interim Report January - June 2026 (Q2)	AQ
08-20	Implantica receives FDA approval for RefluxStop® - Opening the U.S. market	AQ
08-14	Implantica presents the second quarter (Q2 2026) on August 21 at 15:00 CEST	AQ
06-10	Bulletin from the Annual General Meeting of Implantica AG	AQ

More press releases

News in other languages : Implantica AG

08-24	Quadient séduit, Stellantis souffre
08-21	Bourse : Ipsen boucle le rachat de Kartos, la banque italienne en ébullition, Holcim s'offre Fermacell
25-07-01	Les actions en mouvement : Walmart met à mal VusionGroup
25-06-04	Les actions en mouvement : contrats majeurs et commandes importantes
24-09-18	Actualización de las fuertes variaciones del día: Implantica revoluciona el tratamiento del reflujo, Novo Nordisk se enfrenta a la incertidumbre

More news

Managers and Directors : Implantica AG

Manager	Title	Age	Since
Peter Forsell CEO	Chief Executive Officer	72	2014-12-31
Andreas Öhrnberg DFI	Director of Finance/CFO	48	2019-12-31
Stephan Siegenthaler PRN	Corporate Officer/Principal	69	-

Director	Title	Age	Since
Liselott Kilaas CHM	Chairman	67	2019-12-31
Johan Bojs BRD	Director/Board Member	62	2019-12-31
Tomas Puusepp BRD	Director/Board Member	71	2019-12-31

More insiders

Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

11-18 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
26-09-03	SEK 59.40	+0.17%	28,662
26-09-02	SEK 59.30	-2.31%	42,803
26-09-01	SEK 60.70	+0.83%	65,307
26-08-31	SEK 60.20	+0.33%	73,239
26-08-28	SEK 60.00	+0.67%	45,211

Delayed Quote Nasdaq Stockholm

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

5.317EUR

Average target price

8.141EUR

Spread / Average Target

+53.11%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Cap	1.51B 1.75B 1.41B 1.29B 2.41B 166B 2.43B 16.73B 6.51B 84.6B 6.58B 6.43B 272B	P/E 2026 *	-17.8x	P/E 2027 *	-14.4x
Enterprise Value	1.48B 1.72B 1.39B 1.27B 2.37B 162B 2.39B 16.42B 6.39B 83.03B 6.45B 6.31B 267B	EV / Sales 2026 *	431x	EV / Sales 2027 *	165x
Free-Float	-	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Nasdaq Stockholm	IMP A SDB	Delayed
Deutsche Boerse AG	8IM1	Delayed
Börse Stuttgart	8IM1	Delayed
Tradegate	8IM1	Real-time
Boerse Muenchen	8IM1	Real-time

1 day	+0.17%
1 week	-0.34%
Current month	-1.33%
1 month	-2.14%
3 months	+2.41%
6 months	+36.87%
Current year	+18.56%

1 week	58.4	61.9
1 month	50.8	80.3
Current year	38	80.3
1 year	38	80.3
3 years	16	86.4
5 years	15.4	113.2
10 years	15.4	178.9

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/31/26	Liselott Kilaas	Buy	Chairman	28,135	0.0484%
9/24/25	Andreas Öhrnberg	Sell	Chief Financial Officer	16,700	0.0287%
9/24/25	Andreas Öhrnberg	Sell	Chief Financial Officer	17,100	0.0294%

Implantica AG Stock

Stocks

IMP A SDB

SE0014855029

Medical Equipment, Supplies & Distribution

Valuation : Implantica AG

Chart: Implantica AG

Latest news : Implantica AG

Last Transcript : Implantica AG

Analysts' recommendations : Implantica AG

Press Releases : Implantica AG

News in other languages : Implantica AG

Quotes and Performance

Price Extremes

Managers and Directors : Implantica AG

Latest insider transactions

Medical Equipment

Financials

Company Profile

Quotes

Analysts' Consensus

Quarterly revenue - Rate of surprise

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMPLANTICA AG	+0.17%	-0.34%	+0.68%	+134.78%	1.75B
PENUMBRA, INC.	-0.27%	+0.36%	+19.44%	+22.91%	12.71B
GETINGE AB	-0.33%	-0.49%	+19.30%	+27.19%	6.94B
MINIMED GROUP, INC.	+0.59%	+22.30%	-	-	6.67B
ASAHI INTECC CO., LTD.	+0.19%	-8.05%	+37.63%	+23.50%	6.02B
APT MEDICAL INC.	-1.80%	-1.13%	-19.84%	+45.46%	5.08B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	-1.16%	-2.66%	-31.24%	-23.40%	3.85B
NOVOCURE LIMITED	-0.70%	-1.50%	+46.69%	-17.27%	2.08B
NAKANISHI INC.	-1.77%	-6.60%	+45.00%	-16.35%	1.6B
CHEMOMETEC A/S	+7.20%	+2.99%	-0.67%	+20.06%	1.3B
Average	+0.41%	-0.38%	+13.00%	+24.10%	4.8B
Weighted average by Cap.	-0.06%	+1.14%	+13.45%	+23.27%

	2026 *	2027 *
Net sales	3.43M 3.99M 3.22M 2.95M 5.5M 377M 5.55M 38.12M 14.85M 193M 14.99M 14.66M 621M	9.14M 10.63M 8.58M 7.85M 14.65M 1B 14.77M 102M 39.54M 513M 39.91M 39.04M 1.65B
Net income	-20.78M -24.15M -19.5M -17.84M -33.29M -2.28B -33.56M -231M -89.82M -1.17B -90.68M -88.7M -3.76B	-25.61M -29.76M -24.03M -21.99M -41.04M -2.81B -41.36M -284M -111M -1.44B -112M -109M -4.63B
Net Debt	-28.02M -32.57M -26.3M -24.06M -44.91M -3.08B -45.27M -311M -121M -1.57B -122M -120M -5.07B	-1.71M -1.98M -1.6M -1.47M -2.74M -188M -2.76M -18.95M -7.38M -95.84M -7.45M -7.29M -309M